Website được thiết kế tối ưu cho thành viên chính thức. Hãy Đăng nhập hoặc Đăng ký để truy cập đầy đủ nội dung và chức năng. Nội dung bạn cần không thấy trên website, có thể do bạn chưa đăng nhập. Nếu là thành viên của website, bạn cũng có thể yêu cầu trong nhóm Zalo "NCKH Members" các nội dung bạn quan tâm.

Nghiên cứu ứng dụng ghép tế bào gốc tạo máu đồng loại trong bệnh suy tủy xương mức độ nặng với điều kiện hóa Cyclophosphamid và Fludarabine

nckh
Thông tin nghiên cứu
Loại tài liệu
Bài báo trên tạp chí khoa học (Journal Article)
Tiêu đề
Nghiên cứu ứng dụng ghép tế bào gốc tạo máu đồng loại trong bệnh suy tủy xương mức độ nặng với điều kiện hóa Cyclophosphamid và Fludarabine
Tác giả
Võ Thị Thanh Bình; Nguyễn Hữu Chiến; Bạch Quốc Khánh; Nguyễn Anh Trí
Năm xuất bản
2013
Số tạp chí
0
Trang bắt đầu
76-85
ISSN
1859-1868
Abstract

Purpose: Application method of peripheral blood stem cell transplation for severe aplastic anemia on the National Institue of Hematology and Bood Transfusion. Subjects and Methods: Between November 2010 to February 2013, 6 patients with severe aplastic anemia, ( 40 years old, HLA matched donors or = 5/6 aliens) underwent allogeneic HCT on the National Institue of Hematology and Bood Transfusion. Technical process: mobilization, collection and preservation of stem cells collected from peripheral blood donors. The transplant conditioning consisted of CY (120mg/kg), fludarabine (125mg/m2 ) without ATG.. C5A combined with methotrexate was used as GVHD prophylaxis. Monitoring and comprehensive care are in level 1. Definitions: Neutrophil engraftment was defined to have occurred on the first of 3 consecutive days during which the ANC was 0.5 G/L, and to have platelet engraftment occurred on the first 3 consecutive days with a PLT counts 20 G/L without transfusion support. Graft failure: ANC not achieve 0.5 G/L after post-transplant 30 days. Graft rejection: reduced blood cell counts after the initial engraftment. Results: Technical process: mobilization, collection and preservation of stem cells from peripheral blood donors was administered effectively and has reached a high dose: CD34+ was 7.17 - 14.92 x 10 exponent 6 per kg patient waight (average 10.0). Complications: aGVHD grade I and IV was seen in two patients (33.33 percent ) and cGVHD grade I was seen in one patient (16.67 percent ); graft rejection was seen in one patient (16.67 percent ). Engraftment was observed in all six patients, success was seen in 4 patients. Conclusion: Technical process: mobilization, collection and preservation of stem cells from peripheral blood donors was administered_effectively. the authors were able to set up the conditioning regimen consisted of CY and Fludarabin without ATG, which is suitable for Vietnam's current condition. Transplant results was encouraging with a high rate of engraftment of 100 percent . the authors achieved success in 4 patients (66.67 percent ) with long term survival and life quality improvement without blood transfusion. The incidence of aGVHD was seen in two patients (33.33 percent ) and cGVHD in grade I was seen in one patient (16.67 percent ) and there was one case of graft rejection (16.67 percent ).